Dr. Kanti R. Rai
Overview
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY.
Dr. Rai is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
His clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Awards
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
Locations
450 Lakeville Road, Entrance B, Lake Success, NY 11042
Additional Areas of Focus
Dr. Rai has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is highly rated in 48 conditions, according to our data. His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.
New York Queens Medicine And Surgery, P.C.
Giuseppe Giaccone is a Hematologist Oncology specialist and an Oncologist in Flushing, New York. Dr. Giaccone is highly rated in 12 conditions, according to our data. His top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 32 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
Frequently Asked Questions about Dr. Kanti R. Rai
How do I make an appointment with Dr. Kanti R. Rai?
You can book an appointment with Dr. Kanti R. Rai by calling their office at 516-734-8900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kanti R. Rai a top-rated expert for Chronic B-Cell Leukemia (CBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kanti R. Rai is classified as an Elite expert for Chronic B-Cell Leukemia (CBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kanti R. Rai specialize in?
While Dr. Kanti R. Rai is a Hematology Oncology, they have specific expertise in Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Kanti R. Rai participate in research or clinical trials?
Yes. Dr. Kanti R. Rai has published 84 articles and abstracts on conditions like Chronic B-Cell Leukemia (CBCL). You can view a list of Dr. Kanti R. Rai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kanti R. Rai accept my insurance?
Dr. Kanti R. Rai accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 516-734-8900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- LeukemiaDr. Rai isElite. Learn about Leukemia.
- Distinguished
- Hairy Cell Leukemia (HCL)Dr. Rai isDistinguished. Learn about Hairy Cell Leukemia (HCL).
- Richter SyndromeDr. Rai isDistinguished. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Rai isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- Febrile NeutropeniaDr. Rai isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Mountain SicknessDr. Rai isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Rai isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Rai isExperienced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Rai isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Rai isExperienced. Learn about B-Cell Lymphoma.
- Chronic Familial NeutropeniaDr. Rai isExperienced. Learn about Chronic Familial Neutropenia.